amantadine has been researched along with glycine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bigalke, H; Lampe, H | 1 |
| Vamvakidès, A | 2 |
| Khodorov, BI; Koshelev, SG; Sobolevsky, AI | 1 |
| Chen, SH; Kou, HS; Kwan, AL; Lin, FM; Wu, HL; Wu, SM | 1 |
| Blanpied, TA; Clarke, RJ; Johnson, JW | 1 |
| Bourque, M; Di Paolo, T; Dickens, D; Grégoire, L; Patel, W; Snodgrass, R | 1 |
2 review(s) available for amantadine and glycine
| Article | Year |
|---|---|
[Action mechanism of adamantamines: do their activity on glutamatergic receptors intervene in the expression of their pharmacological profile?].
Topics: Amantadine; Antibodies; Antiparkinson Agents; gamma-Aminobutyric Acid; Glycine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 1991 |
[Are there glutamatergic, anti-GABAergic or antiglycinergic components in the action mechanism of adamantamines? Study of convulsions induced by amantadine or 1-adamantylcyclopentanamine in mice].
Topics: Amantadine; Animals; Convulsants; GABA Antagonists; gamma-Aminobutyric Acid; Glutamates; Glycine; Male; Mice; Mice, Inbred BALB C; Seizures | 1990 |
8 other study(ies) available for amantadine and glycine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Modulation of glycine-activated membrane current by adamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Cell Membrane; Cells, Cultured; Chloride Channels; Fetus; gamma-Aminobutyric Acid; Glycine; Ion Channels; Membrane Potentials; Membrane Proteins; Mice; Neurons; Spinal Cord | 1991 |
Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.
Topics: 2-Amino-5-phosphonovalerate; Amantadine; Animals; Aspartic Acid; Evoked Potentials; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; In Vitro Techniques; Memantine; Membrane Potentials; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1998 |
An ionizable chromophoric reagent for the analysis of primary amine-containing drugs by capillary electrophoresis.
Topics: Amantadine; Amines; Drug Stability; Electrophoresis, Capillary; Glycine; Humans; Indicators and Reagents; Methionine; Ofloxacin; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tranexamic Acid | 2005 |
Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.
Topics: Amantadine; Analgesics, Non-Narcotic; Animals; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Embryo, Mammalian; Glycine; Humans; Inhibitory Concentration 50; Ion Channel Gating; Ion Channels; Neural Inhibition; Neurons; Patch-Clamp Techniques; Rats; Receptors, N-Methyl-D-Aspartate; Time Factors; Transfection | 2005 |
AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Glycine; Levodopa; Macaca fascicularis; Neuroprotective Agents; Parkinsonian Disorders; Pilot Projects; Prodrugs; Receptors, N-Methyl-D-Aspartate | 2022 |